Precipio (NASDAQ:PRPO) Stock Price Passes Below 200-Day Moving Average of $1.20

Precipio, Inc. (NASDAQ:PRPOGet Rating)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.20 and traded as low as $0.86. Precipio shares last traded at $0.89, with a volume of 103,768 shares trading hands.

Precipio Stock Performance

The company has a current ratio of 2.19, a quick ratio of 2.04 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $17.73 million, a PE ratio of -1.70 and a beta of 2.09. The firm’s fifty day moving average price is $1.21 and its two-hundred day moving average price is $1.19.

Institutional Investors Weigh In On Precipio

An institutional investor recently bought a new position in Precipio stock. Great Valley Advisor Group Inc. purchased a new stake in Precipio, Inc. (NASDAQ:PRPOGet Rating) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 33,100 shares of the biotechnology company’s stock, valued at approximately $35,000. Great Valley Advisor Group Inc. owned 0.15% of Precipio as of its most recent filing with the SEC. 9.79% of the stock is owned by institutional investors.

Precipio Company Profile

(Get Rating)

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests.

Read More

Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.